drugset / Trial / NCT06450145
Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL
Unknown
15 enrolled
Zhejiang Provincial People's Hospital
First Affiliated Hospital of Zhejiang University · collab
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-arm, open study. After the screening period, arsenic-resistant APL patients were treated with interferon α-2b, arsenic and venetoclax. The efficacy (ORR) and safety were evaluated.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venetoclax | Small molecule | — | — |
| Subject | arsenic trioxide | Small molecule | — | — |
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | — |